RecruitingNot ApplicableNCT06938685

Evaluating the Efficacy NeoThelium FT in the Treatment of Diabetic Foot Ulcers

Evaluation of the Efficacy of NeoThelium FT in the Healing of Chronic Diabetic Foot Ulcers: A Randomized Controlled Multicenter Crossover Trial

Sponsor

NuScience Medical Biologics, LLC

Enrollment

132 participants

Start Date

Oct 6, 2025

Study Type

INTERVENTIONAL

Conditions

Diabetic Foot Ulcer

Summary

This is a randomized controlled crossover trial evaluating the efficacy of NeoThelium FT in conjunction with standard of care vs. standard of care alone in treating diabetic foot ulcers.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying NeoThelium FT and Standard of Care for people with diabetic foot ulcer. The study is currently recruiting participants at 8 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERStandard of Care

Wound cleansing, Sharps debridement, Dressing for moisture balance, Offloading

OTHERNeoThelium FT

NeoThelium FT is a dehydrated wound covering derived from donated human placental tissue. NeoThelium FT is a dual-layer membrane with amnion and chorion combination layers.